Author

E. Guerini-Rocco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

E. Mane· 2 shared N. Fusco· 2 shared A. Marra· 1 shared A. Mazumder· 1 shared B. Weigelt· 1 shared C. Frascarelli· 1 shared C. M. L. Loeffler· 1 shared D. Lozano· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. Mane

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Aberrant cytoplasmic localization of MLH1 characterizes a sub-clonal breast cancer cell population that seeds recurrence

A. Mazumder, T. DeWitt, E. Oropeza, N. Punturi, D. Lozano, E. Sajjadi, E. Guerini-Rocco, K. Venetis, M. Ivanova, E. Mane, N. Fusco, S. Haricharan

This study identifies aberrant cytoplasmic MLH1 localization in sub-clonal breast cancer cells as a driver of endocrine resistance, showing it predicts response to CDK4/6 inhibitors.

bioRxiv · Feb 27, 2024 · PreprintCancer Biology

Multimodal histopathologic models stratify hormone receptor-positive early breast cancer

K. M. Boehm, O. S. M. El Nahhas, A. Marra, P. Selenica, H. Y. Wen, B. Weigelt, E. D. Paul, P. Cekan, R. Erber, C. M. L. Loeffler, E. Guerini-Rocco, N. Fusco, C. Frascarelli, E. Mane, E. Munzone, , J. N. Kather

This paper develops a multimodal transformer model using H&E images and text reports to predict recurrence scores in hormone receptor-positive breast cancer, achieving high accuracy and generalizability.

bioRxiv · Feb 23, 2024Pathology